Key result
Enzymatic infarct size provides a quantitative method to evaluate thrombolytic therapy after acute MI.
Why the study?
There is an urgent need for methods allowing quantitative estimation of myocardial injury to evaluate thrombolytic therapy after acute myocardial infarction.
Key points are not available for this paper at this time.
Design
Other
Answers are grounded in this paper and cite their sources.
Supports enzymatic infarct size for quantifying myocardial injury in AMI; leaves open its role in thrombolytic therapy evaluation.
The February 1990 issue of Circulation contained an editorial comment by Dr. R. Roberts1 concerning our study on enzyme recovery from dog heart.2We appreciate Roberts' interest in our study, and we agree with him that there is urgent need for methods allowing quantitative estimation of myocardial injury.We feel, however, that some of Roberts' remarks could cause confusion
No takes yet. Share an insight, caveat, or question.
Hermens et al. (1990) studied this question. Enzymatic infarct size provides an urgently needed method for the quantitative estimation of myocardial injury to evaluate thrombolytic therapy after acute myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: